Jenacyclin: Full Drug Profile
Jenacyclin - General Information
A synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum). [PubChem]
Pharmacology of Jenacyclin
Jenacyclin, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.
Jenacyclin for patients
Mechanical oral hygiene procedures (i.e., tooth brushing, flossing) should be avoided on any treated areas for 7 days.
Avoid excessive sunlight or artificial ultraviolet light while receiving doxycycline.
Doxycycline may decrease the effectiveness of birth control pills.
Jenacyclin Interactions
Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.
Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracyclines in conjunction with penicillin.
Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
Absorption of tetracycline is impaired by bismuth subsalicylate.
Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
The concurrent use of tetracycline and Penthrane (methoxyflurane) has been reported to result in fatal renal toxicity.
Concurrent use of tetracycline may render oral contraceptives less effective.
Drug/Laboratory Test Interactions
False elevations of urinary catecholamine levels may occur due to interference with the fluorescence test.
Jenacyclin Contraindications
This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
Additional information about Jenacyclin
- Jenacyclin Indication
For the treatment of infections caused by susceptible organisms.
- Mechanism Of Action
- Jenacyclin, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Jenacyclin reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis.
- Drug Interactions
- Acitretin Increased risk of intracranial hypertension
- Food Interactions
- Avoid alcohol.
- Generic Name
- Doxycycline
- Synonyms
- Doxcycline anhydrous; Doxycycline Hyclate; Doxycycline Monohydrate; Doxytetracycline
- Drug Category
- Antimalarials; Anti-Bacterial Agents; Tetracyclines
- Drug Type
- Small Molecule; Approved; Investigational
- Other Brand Names containing Doxycycline
- Alti-Doxycycline; Apo-Doxy; Atridox; Doryx; Doxy 100; Doxy-Caps; Doxy-Lemmon; Doxychel; Doxychel Hyclate; Doxycin; Doxylin; Doxytec; Jenacyclin; Monodox; Novo-Doxylin; Nu-Doxycycline; Periostat; Supracyclin; Vibra-Tabs; Vibramycin; Oracea;
- Absorption
- Completely absorbed following oral administration.
- Toxicity (Overdose)
- Symptoms of overdose include anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region, skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg (I.P. in rat).
- Protein Binding
- >90%
- Biotransformation
- Hepatic
- Half Life
- 18-22 hours
- Dosage Forms of Jenacyclin
- Tablet Oral
- Chemical IUPAC Name
- (2Z,4S,4aR,5S,5aR,6R,12aS)-2-(amino-hydroxymethylidene)-4-dimethylamino-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
- Chemical Formula
- C22H24N2O8
- Doxycycline on Wikipedia
- https://en.wikipedia.org/wiki/Doxycycline
- Organisms Affected
- Enteric bacteria and other eubacteria
